Bicycle Therapeutics Plc. (BCYC) NASDAQ
$14.98 -0.75 (-4.77%)
Market Cap: $466.34M
As of 05/26/22 03:59 PM EDT. Market closed.

Bicycle Therapeutics Plc. (BCYC) NASDAQ
$14.98 -0.75 (-4.77%)
Market Cap: $466.34M
As of 05/26/22 03:59 PM EDT. Market closed.
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity ... read more
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle's lead product candidate, BT1718, a Bicycle Toxin Conjugate (BTC) that targets MT1-MMP, is being investigated in an ongoing Phase I/IIa clinical trial in collaboration with the Centre for Drug Development of Cancer Research UK. Bicycle is also evaluating BT5528, a second-generation BTC targeting EphA2, in a company-sponsored Phase I/II trial. BT8009 is a BTC targeting Nectin-4, a well-validated tumor antigen, and is also currently being evaluated in a Company-sponsored Phase I/II trial. Bicycle is headquartered in Cambridge, UK with many key functions and members of its leadership team located in Lexington, MA. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Milnes Alistair | Chief Operating Officer | Mar 25, 2022 | Option Exercise | $20.12 | 5,155 | 103,719 | 22,480 | Mar 29, 2022, 04:36 PM |
Keen Nicholas | Chief Scientific Officer | Dec 21, 2021 | Option Exercise | $14.00 | 15,477 | 216,678 | 15,477 | Dec 22, 2021, 09:01 PM |
Legault Pierre | Director | Dec 22, 2021 | Option Exercise | $8.48 | 97,860 | 829,853 | 97,860 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 21, 2021 | Option Exercise | $8.44 | 44,537 | 375,892 | 44,537 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 20, 2021 | Option Exercise | $8.41 | 7,603 | 63,941 | 7,603 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 21, 2021 | Sale | $57.11 | 44,537 | 2,543,508 | 0 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 20, 2021 | Sale | $57.02 | 7,603 | 433,523 | 0 | Dec 22, 2021, 09:00 PM |
Legault Pierre | Director | Dec 22, 2021 | Sale | $58.01 | 97,860 | 5,676,858 | 0 | Dec 22, 2021, 09:00 PM |
Lee Kevin | Chief Executive Officer | Oct 18, 2021 | Sale | $60.00 | 49 | 2,940 | 225,085 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 15, 2021 | Sale | $60.05 | 320 | 19,216 | 225,134 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 14, 2021 | Sale | $60.00 | 4,631 | 277,860 | 225,454 | Oct 18, 2021, 06:22 PM |
Lee Kevin | Chief Executive Officer | Oct 11, 2021 | Sale | $53.88 | 5,000 | 269,388 | 230,683 | Oct 13, 2021, 05:28 PM |
Keen Nicholas | Chief Scientific Officer | Oct 01, 2021 | Sale | $45.00 | 1,188 | 53,460 | 2,178 | Oct 05, 2021, 04:16 PM |
Keen Nicholas | Chief Scientific Officer | Oct 05, 2021 | Sale | $45.10 | 2,178 | 98,228 | 0 | Oct 05, 2021, 04:16 PM |
Smethurst Dominic | Chief Medical Officer | Sep 23, 2021 | Option Exercise | $18.55 | 6,000 | 111,300 | 6,000 | Sep 27, 2021, 04:53 PM |
Keen Nicholas | Chief Scientific Officer | Sep 16, 2021 | Sale | $45.01 | 1,955 | 87,995 | 3,366 | Sep 17, 2021, 04:47 PM |
Keen Nicholas | Chief Scientific Officer | Sep 15, 2021 | Sale | $45.00 | 3,000 | 135,000 | 5,321 | Sep 17, 2021, 04:47 PM |
Kalowski Lee | President and CFO | Sep 02, 2021 | Option Exercise | $9.82 | 10,000 | 98,200 | 10,000 | Sep 03, 2021, 04:49 PM |
Kalowski Lee | President and CFO | Sep 02, 2021 | Sale | $40.00 | 10,000 | 400,000 | 0 | Sep 03, 2021, 04:49 PM |
Keen Nicholas | Chief Scientific Officer | Sep 02, 2021 | Sale | $40.00 | 10,000 | 400,000 | 8,321 | Sep 03, 2021, 04:47 PM |
Lee Kevin | Chief Executive Officer | Sep 01, 2021 | Option Exercise | $14.00 | 22,890 | 320,460 | 267,170 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Sep 02, 2021 | Sale | $40.00 | 5,000 | 200,000 | 235,085 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Sep 01, 2021 | Sale | $37.21 | 27,085 | 1,007,897 | 258,979 | Sep 03, 2021, 04:46 PM |
Lee Kevin | Chief Executive Officer | Aug 31, 2021 | Option Exercise | $14.00 | 10,420 | 145,880 | 255,505 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 27, 2021 | Option Exercise | $14.00 | 1,808 | 25,312 | 246,893 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 27, 2021 | Sale | $36.02 | 1,808 | 65,124 | 245,085 | Aug 31, 2021, 05:29 PM |
Lee Kevin | Chief Executive Officer | Aug 31, 2021 | Sale | $36.33 | 11,225 | 407,763 | 245,552 | Aug 31, 2021, 05:29 PM |
Kalowski Lee | President and CFO | Aug 26, 2021 | Option Exercise | $8.76 | 550 | 4,818 | 550 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 27, 2021 | Option Exercise | $8.73 | 7,950 | 69,403 | 7,950 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 26, 2021 | Sale | $35.04 | 550 | 19,272 | 0 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 27, 2021 | Sale | $35.15 | 7,950 | 279,443 | 0 | Aug 27, 2021, 06:31 PM |
Kalowski Lee | President and CFO | Aug 23, 2021 | Option Exercise | $1.60 | 7,500 | 12,000 | 7,500 | Aug 25, 2021, 05:45 PM |
Kalowski Lee | President and CFO | Aug 23, 2021 | Sale | $33.02 | 7,500 | 247,650 | 0 | Aug 25, 2021, 05:45 PM |
Kalowski Lee | President and CFO | Jul 29, 2021 | Option Exercise | $1.63 | 12,500 | 20,375 | 12,500 | Jul 30, 2021, 06:21 PM |
Kalowski Lee | President and CFO | Jul 29, 2021 | Sale | $31.51 | 12,500 | 393,823 | 3,504 | Jul 30, 2021, 06:21 PM |
Lee Kevin | Chief Executive Officer | Jul 26, 2021 | Option Exercise | $14.00 | 100 | 1,400 | 245,185 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 23, 2021 | Option Exercise | $14.00 | 4,782 | 66,948 | 249,867 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 26, 2021 | Sale | $36.00 | 100 | 3,600 | 245,085 | Jul 27, 2021, 07:08 PM |
Lee Kevin | Chief Executive Officer | Jul 23, 2021 | Sale | $36.02 | 4,782 | 172,248 | 245,085 | Jul 27, 2021, 07:08 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 12 | 402 | 39,625 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 43,378 | 1,475,182 | 1,831,671 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 588 | 19,698 | 1,875,049 | Jul 20, 2021, 04:17 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 917 | 31,185 | 38,708 | Jul 20, 2021, 04:17 PM |
Keen Nicholas | Chief Scientific Officer | Jul 14, 2021 | Sale | $35.00 | 10,000 | 350,000 | 18,321 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 16, 2021 | Option Exercise | $14.00 | 609 | 8,526 | 245,694 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 15, 2021 | Option Exercise | $14.00 | 21,970 | 307,580 | 267,055 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 15, 2021 | Sale | $34.28 | 21,970 | 753,132 | 245,085 | Jul 16, 2021, 06:27 PM |
Lee Kevin | Chief Executive Officer | Jul 16, 2021 | Sale | $34.00 | 609 | 20,706 | 245,085 | Jul 16, 2021, 06:27 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 43,378 | 1,475,182 | 1,831,671 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 588 | 19,698 | 1,875,049 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 14, 2021 | Sale | $34.01 | 917 | 31,185 | 38,708 | Jul 15, 2021, 07:03 PM |
BINGHAM KATE | Director | Jul 13, 2021 | Sale | $33.50 | 12 | 402 | 39,625 | Jul 15, 2021, 07:03 PM |
Crockett Nigel | Chief Business Officer | Jul 13, 2021 | Option Exercise | $11.84 | 72,701 | 860,433 | 72,701 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 12, 2021 | Option Exercise | $11.72 | 7,028 | 82,380 | 7,028 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 13, 2021 | Sale | $32.44 | 72,701 | 2,358,362 | 3,121 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 12, 2021 | Sale | $32.03 | 7,028 | 225,107 | 0 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 12, 2021 | Option Exercise | $14.00 | 1,936 | 27,104 | 256,670 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 14, 2021 | Option Exercise | $14.00 | 8,331 | 116,634 | 259,550 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 13, 2021 | Option Exercise | $14.00 | 35,446 | 496,244 | 290,180 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 14, 2021 | Sale | $34.34 | 14,465 | 496,726 | 256,908 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 13, 2021 | Sale | $32.97 | 38,961 | 1,284,680 | 268,201 | Jul 14, 2021, 06:47 PM |
Lee Kevin | Chief Executive Officer | Jul 12, 2021 | Sale | $32.04 | 1,936 | 62,029 | 254,734 | Jul 14, 2021, 06:47 PM |
Crockett Nigel | Chief Business Officer | Jul 06, 2021 | Option Exercise | $9.82 | 271 | 2,661 | 271 | Jul 08, 2021, 05:22 PM |
Crockett Nigel | Chief Business Officer | Jul 06, 2021 | Sale | $32.00 | 271 | 8,672 | 0 | Jul 08, 2021, 05:22 PM |
Lee Kevin | Chief Executive Officer | May 06, 2021 | Option Exercise | $14.00 | 1,716 | 24,024 | 256,450 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 07, 2021 | Option Exercise | $14.00 | 5,604 | 78,456 | 260,338 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 06, 2021 | Sale | $32.14 | 1,716 | 55,152 | 254,734 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | May 07, 2021 | Sale | $32.23 | 5,604 | 180,617 | 254,734 | May 10, 2021, 05:43 PM |
Lee Kevin | Chief Executive Officer | Apr 27, 2021 | Option Exercise | $14.00 | 6,636 | 92,904 | 261,370 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 26, 2021 | Option Exercise | $14.00 | 14,545 | 203,630 | 273,345 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 27, 2021 | Sale | $30.70 | 6,636 | 203,728 | 255,092 | Apr 28, 2021, 04:45 PM |
Lee Kevin | Chief Executive Officer | Apr 26, 2021 | Sale | $31.28 | 18,611 | 582,144 | 268,630 | Apr 28, 2021, 04:45 PM |
Legault Pierre | Director | Apr 08, 2021 | Option Exercise | $8.74 | 24,838 | 217,084 | 24,838 | Apr 09, 2021, 04:36 PM |
Legault Pierre | Director | Apr 08, 2021 | Sale | $31.71 | 24,838 | 787,588 | 12,338 | Apr 09, 2021, 04:36 PM |
Legault Pierre | Director | Apr 05, 2021 | Option Exercise | $8.83 | 162 | 1,430 | 162 | Apr 07, 2021, 07:22 PM |
Legault Pierre | Director | Apr 05, 2021 | Sale | $31.07 | 162 | 5,033 | 0 | Apr 07, 2021, 07:22 PM |
Keen Nicholas | Chief Scientific Officer | Mar 31, 2021 | Sale | $30.00 | 10,000 | 300,000 | 28,321 | Apr 02, 2021, 04:45 PM |
Legault Pierre | Director | Mar 31, 2021 | Option Exercise | $8.78 | 10,000 | 87,800 | 10,000 | Apr 02, 2021, 04:44 PM |
Legault Pierre | Director | Mar 31, 2021 | Sale | $30.00 | 10,000 | 300,000 | 0 | Apr 02, 2021, 04:44 PM |
Legault Pierre | Director | Mar 17, 2021 | Option Exercise | $8.85 | 7,784 | 68,888 | 7,784 | Mar 19, 2021, 04:48 PM |
Legault Pierre | Director | Mar 17, 2021 | Sale | $29.00 | 7,784 | 225,736 | 0 | Mar 19, 2021, 04:48 PM |
Legault Pierre | Director | Mar 12, 2021 | Option Exercise | $8.86 | 2,216 | 19,634 | 2,216 | Mar 16, 2021, 07:42 PM |
Legault Pierre | Director | Mar 12, 2021 | Sale | $29.00 | 2,216 | 64,264 | 0 | Mar 16, 2021, 07:42 PM |
Keen Nicholas | Chief Scientific Officer | Mar 15, 2021 | Sale | $28.00 | 217 | 6,076 | 38,321 | Mar 16, 2021, 07:41 PM |
Keen Nicholas | Chief Scientific Officer | Mar 12, 2021 | Sale | $28.50 | 9,783 | 278,767 | 38,821 | Mar 16, 2021, 07:41 PM |
Lee Kevin | Chief Executive Officer | Feb 05, 2021 | Sale | $31.00 | 100 | 3,100 | 258,800 | Feb 09, 2021, 05:28 PM |
Lee Kevin | Chief Executive Officer | Jan 20, 2021 | Sale | $31.88 | 1,185 | 37,779 | 259,351 | Jan 21, 2021, 04:34 PM |
Lee Kevin | Chief Executive Officer | Jan 19, 2021 | Sale | $29.26 | 5,000 | 146,290 | 260,556 | Jan 21, 2021, 04:34 PM |
Kalowski Lee | President and CFO | Jan 19, 2021 | Option Exercise | $1.59 | 15,000 | 23,850 | 15,000 | Jan 21, 2021, 04:29 PM |
Kalowski Lee | President and CFO | Jan 19, 2021 | Sale | $30.00 | 15,000 | 450,000 | 0 | Jan 21, 2021, 04:29 PM |
Kalowski Lee | President and CFO | Jan 14, 2021 | Option Exercise | $1.60 | 10,000 | 16,000 | 10,000 | Jan 15, 2021, 04:44 PM |
Kalowski Lee | President and CFO | Jan 14, 2021 | Sale | $25.00 | 10,000 | 250,000 | 0 | Jan 15, 2021, 04:44 PM |
Lee Kevin | Chief Executive Officer | Jan 14, 2021 | Sale | $25.00 | 5,000 | 125,000 | 270,085 | Jan 15, 2021, 04:40 PM |
Lee Kevin | Chief Executive Officer | Jan 15, 2021 | Sale | $27.01 | 5,000 | 135,050 | 265,085 | Jan 15, 2021, 04:40 PM |
Kalowski Lee | President and CFO | Dec 01, 2020 | Option Exercise | $1.56 | 7,500 | 11,700 | 7,500 | Dec 03, 2020, 08:53 PM |
Kalowski Lee | President and CFO | Dec 01, 2020 | Sale | $22.50 | 7,500 | 168,750 | 0 | Dec 03, 2020, 08:53 PM |
Kalowski Lee | President and CFO | Nov 27, 2020 | Option Exercise | $1.56 | 530 | 827 | 530 | Nov 30, 2020, 04:42 PM |
Kalowski Lee | President and CFO | Nov 27, 2020 | Sale | $20.00 | 530 | 10,600 | 0 | Nov 30, 2020, 04:42 PM |
Kalowski Lee | President and CFO | Nov 25, 2020 | Option Exercise | $1.56 | 9,781 | 15,258 | 9,781 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 23, 2020 | Option Exercise | $1.56 | 17,189 | 26,815 | 17,189 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 25, 2020 | Sale | $20.07 | 9,781 | 196,305 | 0 | Nov 25, 2020, 08:31 PM |
Kalowski Lee | President and CFO | Nov 23, 2020 | Sale | $19.83 | 17,189 | 340,805 | 213 | Nov 25, 2020, 08:31 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Jul 15, 2020 | Sale | $19.40 | 3,147 | 61,045 | 1,910,609 | Sep 18, 2020, 12:04 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Jul 14, 2020 | Sale | $19.27 | 1,597 | 30,781 | 1,913,678 | Sep 18, 2020, 12:04 PM |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 10% Owner | May 28, 2019 | Buy | $14.00 | 364,286 | 5,100,004 | 1,957,961 | Jun 03, 2019, 05:15 PM |
Cambridge Innovation Capital (Jersey) Ltd | 10% Owner | May 29, 2019 | Buy | $14.00 | 314,286 | 4,400,004 | 1,751,437 | May 31, 2019, 05:12 PM |
Novartis Bioventures Ltd | 10% Owner | May 28, 2019 | Buy | $14.00 | 168,630 | 2,360,820 | 1,769,641 | May 30, 2019, 09:27 PM |
NG CAROLYN | Director | May 27, 2019 | Buy | $14.00 | 571,429 | 8,000,006 | 571,429 | May 30, 2019, 09:27 PM |
SVLSF V, LLC | 10% Owner | May 28, 2019 | Buy | $14.00 | 7,983 | 111,762 | 39,637 | May 30, 2019, 09:26 PM |
SVLSF V, LLC | 10% Owner | May 28, 2019 | Buy | $14.00 | 377,732 | 5,288,248 | 1,875,637 | May 30, 2019, 09:26 PM |
Anstey Michael | Director | May 28, 2019 | Buy | $14.00 | 314,286 | 4,400,004 | 1,751,437 | May 30, 2019, 09:26 PM |
BINGHAM KATE | Director | May 28, 2019 | Buy | $14.00 | 7,983 | 111,762 | 39,637 | May 30, 2019, 09:26 PM |
BINGHAM KATE | Director | May 28, 2019 | Buy | $14.00 | 377,732 | 5,288,248 | 1,875,637 | May 30, 2019, 09:26 PM |
HARLAND DEBORAH | Director | May 28, 2019 | Buy | $14.00 | 385,714 | 5,399,996 | 1,915,275 | May 30, 2019, 09:25 PM |
GLAXOSMITHKLINE PLC | Director | May 28, 2019 | Buy | $14.00 | 385,714 | 5,399,996 | 1,915,275 | May 30, 2019, 05:47 PM |
Owner | Relationship | Date | Value($) |
Milnes Alistair | Chief Operating Officer | 03/25/2022 | 103,719 |
Keen Nicholas | Chief Scientific Officer | 12/21/2021 | 216,678 |
Legault Pierre | Director | 12/22/2021 | 829,853 |
Legault Pierre | Director | 12/21/2021 | 375,892 |
Legault Pierre | Director | 12/20/2021 | 63,941 |
Legault Pierre | Director | 12/21/2021 | 2,543,508 |
Legault Pierre | Director | 12/20/2021 | 433,523 |
Legault Pierre | Director | 12/22/2021 | 5,676,858 |
Lee Kevin | Chief Executive Officer | 10/18/2021 | 2,940 |
Lee Kevin | Chief Executive Officer | 10/15/2021 | 19,216 |
Lee Kevin | Chief Executive Officer | 10/14/2021 | 277,860 |
Lee Kevin | Chief Executive Officer | 10/11/2021 | 269,388 |
Keen Nicholas | Chief Scientific Officer | 10/01/2021 | 53,460 |
Keen Nicholas | Chief Scientific Officer | 10/05/2021 | 98,228 |
Smethurst Dominic | Chief Medical Officer | 09/23/2021 | 111,300 |
Keen Nicholas | Chief Scientific Officer | 09/16/2021 | 87,995 |
Keen Nicholas | Chief Scientific Officer | 09/15/2021 | 135,000 |
Kalowski Lee | President and CFO | 09/02/2021 | 98,200 |
Kalowski Lee | President and CFO | 09/02/2021 | 400,000 |
Keen Nicholas | Chief Scientific Officer | 09/02/2021 | 400,000 |
Lee Kevin | Chief Executive Officer | 09/01/2021 | 320,460 |
Lee Kevin | Chief Executive Officer | 09/02/2021 | 200,000 |
Lee Kevin | Chief Executive Officer | 09/01/2021 | 1,007,897 |
Lee Kevin | Chief Executive Officer | 08/31/2021 | 145,880 |
Lee Kevin | Chief Executive Officer | 08/27/2021 | 25,312 |
Lee Kevin | Chief Executive Officer | 08/27/2021 | 65,124 |
Lee Kevin | Chief Executive Officer | 08/31/2021 | 407,763 |
Kalowski Lee | President and CFO | 08/26/2021 | 4,818 |
Kalowski Lee | President and CFO | 08/27/2021 | 69,403 |
Kalowski Lee | President and CFO | 08/26/2021 | 19,272 |
Kalowski Lee | President and CFO | 08/27/2021 | 279,443 |
Kalowski Lee | President and CFO | 08/23/2021 | 12,000 |
Kalowski Lee | President and CFO | 08/23/2021 | 247,650 |
Kalowski Lee | President and CFO | 07/29/2021 | 20,375 |
Kalowski Lee | President and CFO | 07/29/2021 | 393,823 |
Lee Kevin | Chief Executive Officer | 07/26/2021 | 1,400 |
Lee Kevin | Chief Executive Officer | 07/23/2021 | 66,948 |
Lee Kevin | Chief Executive Officer | 07/26/2021 | 3,600 |
Lee Kevin | Chief Executive Officer | 07/23/2021 | 172,248 |
BINGHAM KATE | Director | 07/13/2021 | 402 |
BINGHAM KATE | Director | 07/14/2021 | 1,475,182 |
BINGHAM KATE | Director | 07/13/2021 | 19,698 |
BINGHAM KATE | Director | 07/14/2021 | 31,185 |
Keen Nicholas | Chief Scientific Officer | 07/14/2021 | 350,000 |
Lee Kevin | Chief Executive Officer | 07/16/2021 | 8,526 |
Lee Kevin | Chief Executive Officer | 07/15/2021 | 307,580 |
Lee Kevin | Chief Executive Officer | 07/15/2021 | 753,132 |
Lee Kevin | Chief Executive Officer | 07/16/2021 | 20,706 |
BINGHAM KATE | Director | 07/14/2021 | 1,475,182 |
BINGHAM KATE | Director | 07/13/2021 | 19,698 |
BINGHAM KATE | Director | 07/14/2021 | 31,185 |
BINGHAM KATE | Director | 07/13/2021 | 402 |
Crockett Nigel | Chief Business Officer | 07/13/2021 | 860,433 |
Crockett Nigel | Chief Business Officer | 07/12/2021 | 82,380 |
Crockett Nigel | Chief Business Officer | 07/13/2021 | 2,358,362 |
Crockett Nigel | Chief Business Officer | 07/12/2021 | 225,107 |
Lee Kevin | Chief Executive Officer | 07/12/2021 | 27,104 |
Lee Kevin | Chief Executive Officer | 07/14/2021 | 116,634 |
Lee Kevin | Chief Executive Officer | 07/13/2021 | 496,244 |
Lee Kevin | Chief Executive Officer | 07/14/2021 | 496,726 |
Lee Kevin | Chief Executive Officer | 07/13/2021 | 1,284,680 |
Lee Kevin | Chief Executive Officer | 07/12/2021 | 62,029 |
Crockett Nigel | Chief Business Officer | 07/06/2021 | 2,661 |
Crockett Nigel | Chief Business Officer | 07/06/2021 | 8,672 |
Lee Kevin | Chief Executive Officer | 05/06/2021 | 24,024 |
Lee Kevin | Chief Executive Officer | 05/07/2021 | 78,456 |
Lee Kevin | Chief Executive Officer | 05/06/2021 | 55,152 |
Lee Kevin | Chief Executive Officer | 05/07/2021 | 180,617 |
Lee Kevin | Chief Executive Officer | 04/27/2021 | 92,904 |
Lee Kevin | Chief Executive Officer | 04/26/2021 | 203,630 |
Lee Kevin | Chief Executive Officer | 04/27/2021 | 203,728 |
Lee Kevin | Chief Executive Officer | 04/26/2021 | 582,144 |
Legault Pierre | Director | 04/08/2021 | 217,084 |
Legault Pierre | Director | 04/08/2021 | 787,588 |
Legault Pierre | Director | 04/05/2021 | 1,430 |
Legault Pierre | Director | 04/05/2021 | 5,033 |
Keen Nicholas | Chief Scientific Officer | 03/31/2021 | 300,000 |
Legault Pierre | Director | 03/31/2021 | 87,800 |
Legault Pierre | Director | 03/31/2021 | 300,000 |
Legault Pierre | Director | 03/17/2021 | 68,888 |
Legault Pierre | Director | 03/17/2021 | 225,736 |
Legault Pierre | Director | 03/12/2021 | 19,634 |
Legault Pierre | Director | 03/12/2021 | 64,264 |
Keen Nicholas | Chief Scientific Officer | 03/15/2021 | 6,076 |
Keen Nicholas | Chief Scientific Officer | 03/12/2021 | 278,767 |
Lee Kevin | Chief Executive Officer | 02/05/2021 | 3,100 |
Lee Kevin | Chief Executive Officer | 01/20/2021 | 37,779 |
Lee Kevin | Chief Executive Officer | 01/19/2021 | 146,290 |
Kalowski Lee | President and CFO | 01/19/2021 | 23,850 |
Kalowski Lee | President and CFO | 01/19/2021 | 450,000 |
Kalowski Lee | President and CFO | 01/14/2021 | 16,000 |
Kalowski Lee | President and CFO | 01/14/2021 | 250,000 |
Lee Kevin | Chief Executive Officer | 01/14/2021 | 125,000 |
Lee Kevin | Chief Executive Officer | 01/15/2021 | 135,050 |
Kalowski Lee | President and CFO | 12/01/2020 | 11,700 |
Kalowski Lee | President and CFO | 12/01/2020 | 168,750 |
Kalowski Lee | President and CFO | 11/27/2020 | 827 |
Kalowski Lee | President and CFO | 11/27/2020 | 10,600 |
Kalowski Lee | President and CFO | 11/25/2020 | 15,258 |
Kalowski Lee | President and CFO | 11/23/2020 | 26,815 |
Kalowski Lee | President and CFO | 11/25/2020 | 196,305 |
Kalowski Lee | President and CFO | 11/23/2020 | 340,805 |
GLAXOSMITHKLINE PLC | 10% Owner | 07/15/2020 | 61,045 |
GLAXOSMITHKLINE PLC | 10% Owner | 07/14/2020 | 30,781 |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 10% Owner | 05/28/2019 | 5,100,004 |
Cambridge Innovation Capital (Jersey) Ltd | 10% Owner | 05/29/2019 | 4,400,004 |
Novartis Bioventures Ltd | 10% Owner | 05/28/2019 | 2,360,820 |
NG CAROLYN | Director | 05/27/2019 | 8,000,006 |
SVLSF V, LLC | 10% Owner | 05/28/2019 | 111,762 |
SVLSF V, LLC | 10% Owner | 05/28/2019 | 5,288,248 |
Anstey Michael | Director | 05/28/2019 | 4,400,004 |
BINGHAM KATE | Director | 05/28/2019 | 111,762 |
BINGHAM KATE | Director | 05/28/2019 | 5,288,248 |
HARLAND DEBORAH | Director | 05/28/2019 | 5,399,996 |
GLAXOSMITHKLINE PLC | Director | 05/28/2019 | 5,399,996 |
Period of Report: 03/31/2022
10-K/10-Q Filings: View